Ollin Biosciences (Series B)
Funding Details
Awarder
Inbox
Date Award
July 1, 2026
Vertical
Biopharmaceuticals
Funding URL
View Funding Page
Funding Amount
$330,000,000
Company Info
Founding Year
2023
Founders
Jason Ehrlich
Market
Ophthalmology
Location
West Lake Hills, Texas, United States
Coinvestors
Andreessen Horowitz, ARCH Venture Partners, Blackstone, Canada Pension Plan Investment Board, Commodore Capital, Monograph Capital, Mubadala Capital, RA Capital Management, T. Rowe Price Associates, TCG
Company Description

Ollin Biosciences™ is a clinical-stage biopharmaceutical company dedicated to acquiring and developing best-in-disease therapies for vision-threatening diseases. With a differentiated pipeline, world-class team, and strong investor syndicate, Ollin is redefining what's possible in ophthalmology.

Links
Website
Back to HomeBack to Biopharmaceuticals DealsView Funding Announcement